The IPO Guide Analysing an Issue

How to Read an RHP in Under Two Hours

A red herring prospectus runs to hundreds of pages. Six sections carry almost all the decision-relevant information — here is what they are, in the order worth reading them.

4 min readGuide 18 of 26Updated

An RHP is written by lawyers to be complete, not to be read. Most of it is boilerplate, industry-report filler and statutory disclosure that applies identically to every issue.

Six sections are not. Read those and you will know more about the issue than the overwhelming majority of people applying to it.

1. Risk factors

Start here, not with the business description.

Risk factors must be ordered by materiality and quantified where possible. That ordering is the company’s own assessment, arrived at with its lawyers, of what could most plausibly damage it. The first ten entries are worth reading word for word.

What to look for specifically:

  • Concentration. One customer at 40 percent of revenue, one plant, one geography, one product, one supplier.
  • Regulatory dependence. A licence, subsidy or approval the business cannot operate without.
  • Negative operating cash flow in any recent year — always disclosed, easily missed.
  • Promoter litigation and regulatory action, including matters involving group companies.
  • Contingent liabilities, with amounts. Compare the total against net worth.
  • Qualified audit opinions or emphasis of matter.

A risk factor stating that the company has had negative cash flows in each of the last three years is not boilerplate, however routine the surrounding language sounds.

2. Objects of the issue

Where the fresh issue money actually goes, line by line.

Check three things. Whether the objects are specific — a named plant with a costed schedule reads very differently from “funding growth initiatives”. How much sits under general corporate purposes, which SEBI caps precisely because it means undecided. And whether a large share goes to repaying debt, which is legitimate but is deleveraging rather than expansion.

Then compare the fresh issue against the offer for sale. If the OFS dwarfs the fresh issue, the issue is primarily an exit, and the growth narrative in the prospectus is describing something the IPO is not funding.

3. Basis for issue price

The company’s own argument for its valuation, and the most concentrated page in the document.

It gives EPS, P/E, RoNW and NAV at both the floor and the cap price, sets out the qualitative strengths management relies on, and lists the key performance indicators the board actually tracks — which is more revealing than the ones chosen for the marketing deck.

It also discloses the price paid in recent pre-IPO transactions and the weighted average cost of acquisition for selling shareholders. If a private placement six months ago went through at a third of the IPO price, that is a fact worth sitting with.

4. Peer comparison

A table of listed comparables on revenue, EPS, P/E, RoNW and NAV.

Treat it as advocacy. The peer set is selected by the issuer, and the selection is where the work happens — a mid-sized regional player compared against national leaders will look cheap on every metric for reasons that have nothing to do with value.

Check that the comparables are genuinely similar in scale, margin structure and growth rate. Then check whether obvious peers are missing.

Sales to promoter-owned entities, purchases from them, loans, guarantees, rent, royalties, management fees.

Related-party dealings are not inherently improper and most large groups have them. What matters is scale and direction. If a material share of revenue comes from entities the promoter controls, the revenue quality is not what the growth chart implies. If cash regularly moves out to group entities, ask why.

6. Financial statements

The restated financials cover three years. You do not need to model them, but four checks are worth doing by hand:

  • Revenue growth versus profit growth. Profit growing much faster usually means margin expansion that needs an explanation.
  • Operating cash flow versus net profit. Persistent profit without cash is the classic warning.
  • Receivable days trending up — revenue recognised but not collected.
  • The restatement adjustments themselves, which show where previously reported figures were revised.

Also note the cut-off. A prospectus with financials ending nine months ago is telling you less about the present than it appears to.

The DRHP-to-RHP delta

If the company filed its DRHP many months earlier, put the two documents side by side.

New risk factors, updated financials that reveal a slowdown, a shrunken fresh issue after a pre-IPO placement, changes in who is selling and how much — the differences are often more informative than either document alone, and almost nobody looks.

A workable two-hour plan

Minutes Section
10 Abridged prospectus, cover to cover
30 Risk factors, top twenty
15 Objects of the issue
15 Basis for issue price and peer comparison
20 Related-party transactions and litigation summary
30 Three-year financials and the four checks above

That will not make you an analyst. It will reliably keep you out of the issues that were obviously going to disappoint.

Frequently asked questions

Where do I get the RHP?

The BSE and NSE host it for issues on their platforms, and the lead managers and issuer publish it. SEBI's site carries the earlier DRHP. The abridged prospectus, accessible from the QR code on the application form, is a good starting point.

Are risk factors just legal boilerplate?

Some are, but they must be ordered by materiality and quantified where possible. That ordering is the company's own judgement about what could hurt it most, which makes the top of the list genuinely informative.

Should I trust the peer comparison table?

Treat it as the company's argument, not as neutral analysis. The peer set is chosen by the issuer. Check the comparables are similar in size, margin and growth before drawing conclusions from the multiples.

Run this process at network scale.

BidFlow handles bulk applications, ASBA form printing, live subscription and GMP data, and one-click allotment checks across every branch.

Book a Demo
Chat with us